Business Context and Reporting Period
Company: Orthodontix, Inc. (Note: Input metadata referenced Protalix Biotherapeutics, but the filing text is for Orthodontix, Inc.)
Filing Type: Form 10-KSB (Annual Report)
Period: Fiscal Year Ended December 31, 2005
Status: Shell Company / Pre-Acquisition Vehicle
Orthodontix, Inc. ceased its original orthodontic practice management operations in 1999 and terminated all practice affiliations by 2001. As of the reporting period, the Company operates as a shell company with no active business operations, devoting management time exclusively to identifying potential merger or acquisition candidates in industries such as health care, manufacturing, and banking.
Key Financial Metrics
| Metric | 2005 | 2004 |
|---|---|---|
| Revenue | $0 | $0 |
| Net Loss | $(74,931) | $(160,070) |
| Loss Per Share (Basic/Diluted) | $(0.02) | $(0.05) |
| General & Administrative Expenses | $93,295 | $165,582 |
| Interest Income | $14,150 | $5,512 |
| Cash and Cash Equivalents (Year End) | $985,238 | $563,713 |
| Total Liabilities | $72,930 | Filing text does not provide a clear total for 2004 |
| Stockholders' Equity | $914,431 | $495,362 |
Material Changes vs. Prior Period
- Reduced Operating Loss: Net loss decreased by approximately 53% from $160,070 in 2004 to $74,931 in 2005, primarily due to a significant reduction in General and Administrative expenses (down from $165,582 to $93,295).
- Capital Raise: In November 2005, the Company sold 2,915,428 shares of common stock to an existing shareholder for $494,000. This transaction resulted in a change of majority control to a previously unrelated third party.
- Increased Liquidity: Cash and cash equivalents increased by $421,525 to $985,238, driven by the proceeds from the stock issuance and higher interest income ($14,150 vs. $5,512).
- Stock Price Volatility: While trading between $0.11 and $0.21 for most of 2005, the stock price spiked to a high of $5.50 in the fourth quarter, coinciding with the capital raise.
Outlook, Risks, and Management Commentary
- Plan of Operation: Management intends to effect a merger, acquisition, or business combination using a combination of common stock, cash on hand, or other funding sources. No assurances are given that a transaction will occur.
- Liquidity: Management believes current operating funds ($985,238) are sufficient to cover expenses for at least the next twelve months. The Company has no ongoing contractual commitments.
- Risks: The Company is a shell company with no revenue. Success depends entirely on consummating a business combination. There is a risk that funding sources may not be available or that a transaction cannot be completed on favorable terms.
- Accountant Changes: The Company changed auditors twice in recent years. PricewaterhouseCoopers resigned in 2004; Salberg & Co. was engaged in 2005 but dismissed in September 2005; Sherb and Company, LLP was engaged to audit the 2005 statements. No disagreements were reported regarding accounting principles.
Investor Verification Checklist
- Shell Status: Verify the Company's status as a shell company with no operating revenue and its reliance on a future merger for viability.
- Change of Control: Confirm the details of the November 2005 stock sale that transferred majority control to a new third-party shareholder.
- Cash Runway: Assess the sustainability of the $985,000 cash balance against the historical burn rate of ~$75,000 annually.
- Related Party Transactions: Review the compensation of the CFO (paid via an accounting firm where he is a shareholder) and the rent-free office space provided by Transworld Investment Corporation (TIC), where the CEO and a Director are officers.
- Accumulated Deficit: Note the significant accumulated deficit of approximately $3.8 million as of December 31, 2005.